These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22429722

  • 21. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct 15; 155(8):1113-33. PubMed ID: 8873639
    [Abstract] [Full Text] [Related]

  • 22. Adjuvant bisphosphonates: a new standard of care?
    Gnant M.
    Curr Opin Oncol; 2012 Nov 15; 24(6):635-42. PubMed ID: 23042123
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
    Sijanovic S, Karner I.
    Medscape Womens Health; 2001 Oct 15; 6(5):3. PubMed ID: 11698925
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies.
    Coleman RE, Body JJ, Gralow JR, Lipton A.
    Cancer Treat Rev; 2008 Oct 15; 34 Suppl 1():S31-42. PubMed ID: 18486346
    [Abstract] [Full Text] [Related]

  • 30. Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer.
    Swenson KK, Henly SJ, Shapiro AC, Schroeder LM.
    Clin J Oncol Nurs; 2005 Apr 15; 9(2):177-84. PubMed ID: 15853161
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Treatment strategies for patients with low bone mass: the younger postmenopausal female.
    Honig S.
    Bull NYU Hosp Jt Dis; 2008 Apr 15; 66(3):240-3. PubMed ID: 18937639
    [Abstract] [Full Text] [Related]

  • 33. Cancer treatment-induced bone loss.
    Adler RA.
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec 15; 14(6):442-5. PubMed ID: 17982349
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Skeletal morbidity in inflammatory bowel disease.
    van Hogezand RA, Hamdy NA.
    Scand J Gastroenterol Suppl; 2006 Dec 15; (243):59-64. PubMed ID: 16782623
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Osteoporosis--a review.
    Alden JC.
    Clin Ther; 1989 Dec 15; 11(1):3-14. PubMed ID: 2655904
    [Abstract] [Full Text] [Related]

  • 39. Bisphosphonates: ready for use as adjuvant therapy of breast cancer?
    Theriault RL.
    Curr Opin Obstet Gynecol; 2010 Feb 15; 22(1):61-6. PubMed ID: 19934757
    [Abstract] [Full Text] [Related]

  • 40. Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.
    Yonehara Y, Iwamoto I, Kosha S, Rai Y, Sagara Y, Douchi T.
    J Obstet Gynaecol Res; 2007 Oct 15; 33(5):696-9. PubMed ID: 17845332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.